The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Hospital Acquired Infections Control-Global Market Insights and Sales Trends 2024
Synopsis
Infection control in health care facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acquired during the course of health care is known as a nosocomial, or hospital acquired, infection. The infection may occur in a postoperative wound or as a complication unrelated to the disease or condition.
The global Hospital Acquired Infections Control market size is expected to reach US$ 6985.5 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainly driven by the significant applications of Hospital Acquired Infections Control in various end use industries. The expanding demands from the General Hospital and Infectious Disease Hospital, are propelling Hospital Acquired Infections Control market. Education, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Medical Device Disinfection segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hospital Acquired Infections Control, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hospital Acquired Infections Control market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hospital Acquired Infections Control market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hospital Acquired Infections Control sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hospital Acquired Infections Control covered in this report include AstraZeneca, GlaxoSmithKline, Merck and Pfizer, etc.
The global Hospital Acquired Infections Control market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
GlaxoSmithKline
Merck
Pfizer
Global Hospital Acquired Infections Control market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hospital Acquired Infections Control market, Segment by Type:
Education
Medical Device Disinfection
Screening
Environmental Control
Global Hospital Acquired Infections Control market, by Application
General Hospital
Infectious Disease Hospital
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Hospital Acquired Infections Control companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Infection control in health care facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acquired during the course of health care is known as a nosocomial, or hospital acquired, infection. The infection may occur in a postoperative wound or as a complication unrelated to the disease or condition.
The global Hospital Acquired Infections Control market size is expected to reach US$ 6985.5 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainly driven by the significant applications of Hospital Acquired Infections Control in various end use industries. The expanding demands from the General Hospital and Infectious Disease Hospital, are propelling Hospital Acquired Infections Control market. Education, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Medical Device Disinfection segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hospital Acquired Infections Control, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hospital Acquired Infections Control market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hospital Acquired Infections Control market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hospital Acquired Infections Control sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hospital Acquired Infections Control covered in this report include AstraZeneca, GlaxoSmithKline, Merck and Pfizer, etc.
The global Hospital Acquired Infections Control market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
GlaxoSmithKline
Merck
Pfizer
Global Hospital Acquired Infections Control market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hospital Acquired Infections Control market, Segment by Type:
Education
Medical Device Disinfection
Screening
Environmental Control
Global Hospital Acquired Infections Control market, by Application
General Hospital
Infectious Disease Hospital
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Hospital Acquired Infections Control companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Hospital Acquired Infections Control
1.1 Hospital Acquired Infections Control Market Overview
1.1.1 Hospital Acquired Infections Control Product Scope
1.1.2 Hospital Acquired Infections Control Market Status and Outlook
1.2 Global Hospital Acquired Infections Control Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Hospital Acquired Infections Control Market Size by Region (2018-2029)
1.4 Global Hospital Acquired Infections Control Historic Market Size by Region (2018-2023)
1.5 Global Hospital Acquired Infections Control Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Hospital Acquired Infections Control Market Size (2018-2029)
1.6.1 North America Hospital Acquired Infections Control Market Size (2018-2029)
1.6.2 Europe Hospital Acquired Infections Control Market Size (2018-2029)
1.6.3 Asia-Pacific Hospital Acquired Infections Control Market Size (2018-2029)
1.6.4 Latin America Hospital Acquired Infections Control Market Size (2018-2029)
1.6.5 Middle East & Africa Hospital Acquired Infections Control Market Size (2018-2029)
2 Hospital Acquired Infections Control Market by Type
2.1 Introduction
2.1.1 Education
2.1.2 Medical Device Disinfection
2.1.3 Screening
2.1.4 Environmental Control
2.2 Global Hospital Acquired Infections Control Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Hospital Acquired Infections Control Historic Market Size by Type (2018-2023)
2.2.2 Global Hospital Acquired Infections Control Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Hospital Acquired Infections Control Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Hospital Acquired Infections Control Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Hospital Acquired Infections Control Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Hospital Acquired Infections Control Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Hospital Acquired Infections Control Revenue Breakdown by Type (2018-2029)
3 Hospital Acquired Infections Control Market Overview by Application
3.1 Introduction
3.1.1 General Hospital
3.1.2 Infectious Disease Hospital
3.2 Global Hospital Acquired Infections Control Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Hospital Acquired Infections Control Historic Market Size by Application (2018-2023)
3.2.2 Global Hospital Acquired Infections Control Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Hospital Acquired Infections Control Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Hospital Acquired Infections Control Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Hospital Acquired Infections Control Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Hospital Acquired Infections Control Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Hospital Acquired Infections Control Revenue Breakdown by Application (2018-2029)
4 Hospital Acquired Infections Control Competition Analysis by Players
4.1 Global Hospital Acquired Infections Control Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hospital Acquired Infections Control as of 2022)
4.3 Date of Key Players Enter into Hospital Acquired Infections Control Market
4.4 Global Top Players Hospital Acquired Infections Control Headquarters and Area Served
4.5 Key Players Hospital Acquired Infections Control Product Solution and Service
4.6 Competitive Status
4.6.1 Hospital Acquired Infections Control Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AstraZeneca
5.1.1 AstraZeneca Profile
5.1.2 AstraZeneca Main Business
5.1.3 AstraZeneca Hospital Acquired Infections Control Products, Services and Solutions
5.1.4 AstraZeneca Hospital Acquired Infections Control Revenue (US$ Million) & (2018-2023)
5.1.5 AstraZeneca Recent Developments
5.2 GlaxoSmithKline
5.2.1 GlaxoSmithKline Profile
5.2.2 GlaxoSmithKline Main Business
5.2.3 GlaxoSmithKline Hospital Acquired Infections Control Products, Services and Solutions
5.2.4 GlaxoSmithKline Hospital Acquired Infections Control Revenue (US$ Million) & (2018-2023)
5.2.5 GlaxoSmithKline Recent Developments
5.3 Merck
5.3.1 Merck Profile
5.3.2 Merck Main Business
5.3.3 Merck Hospital Acquired Infections Control Products, Services and Solutions
5.3.4 Merck Hospital Acquired Infections Control Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Hospital Acquired Infections Control Products, Services and Solutions
5.4.4 Pfizer Hospital Acquired Infections Control Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Recent Developments
6 North America
6.1 North America Hospital Acquired Infections Control Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Hospital Acquired Infections Control Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Hospital Acquired Infections Control Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Hospital Acquired Infections Control Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Hospital Acquired Infections Control Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Hospital Acquired Infections Control Market Dynamics
11.1 Hospital Acquired Infections Control Industry Trends
11.2 Hospital Acquired Infections Control Market Drivers
11.3 Hospital Acquired Infections Control Market Challenges
11.4 Hospital Acquired Infections Control Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
